Objective: Accumulating evidence suggests that macrophages are involved in the immunoediting of oral squamous cell carcinoma but the role of macrophages in oral carcinogenesis is unclear. We aimed to clarify the role of macrophages in oral leukoplakia, which is the most common oral potentially malignant disorder from immunotolerance viewpoint. 
| INTRODUCTION
The oral cavity plays an essential role in eating, speaking, swallowing, and facial aesthetics (Matsuhira et al., 2015) . Oral squamous cell carcinoma (OSCC) is a solid tumour of epithelial origin that has been reported to affect approximately 400,000 people annually worldwide (Petersen, 2009) . The mortality rate of OSCC has remained largely unchanged for the last several decades, with a 5-year survival rate <50% (Petruzzi, Cherubini, Salum, & de Figueiredo, 2017) . The early detection of OSCC is thus very important for high patient quality of life.
It was reported that most of OSCCs pass through a premalignant stage (Liu et al., 2017) . Oral leukoplakia (OL) is the most common oral potentially malignant disorder. OL occurs most frequently in the tongue. OL is defined as a white plaque of questionable risk having excluded other diseases or disorders that carry no increased risk for factor (Woo, 2019) . OL is only a clinical term, and its presentation including clinical appearance, colour, and surface type can vary (Irani, 2016; Shafer & Waldron, 1961) . It has been reported that approximately 3.5% (0.13-34.0%) of OLs develop into OSCC (Warnakulasuriya & Ariyawardana, 2016) . Previous reports have suggested the proliferation marker Ki-67 and the squamous celldifferentiation markers cytokeratin (CK) 13 and CK17 may be the factors for biological malignancy of oral atypical epithelium (Kitamura et al., 2012; Kövesi & Szende, 2003; Mikami et al., 2015) . For example, immunohistochemical Ki-67 expression have been sporadically confirmed in the second basal layer of normal epithelium, but many + cells are distributed to the basal and/or more superficial layers of oral precancerous lesions. Additionally, CK13 is expressed in normal epithelium but not precancerous lesions, whereas CK17 is expressed in precancerous lesions but not in normal epithelium (Yagyuu et al., 2015) . However, the mechanism of OL development has not been completely elucidated to date. Thus, a better understanding of the underlying molecular mechanisms of oral carcinogenesis is necessary.
Macrophages (MΦs) are considered the main cancer stromal cells, and tumour-associated MΦ (TAM) infiltration has been found to correlate with a poor prognosis in various cancers (Lewis & Pollard, 2006; Mantovani, Sozzani, Locati, Allavena, & Sica, 2002; Takeya & Komohara, 2016) . From an oncological viewpoint, MΦs have two different functions, as tumour suppressive cells (M1 MΦs) and tumour support cells (M2 MΦs; Goerdt & Orfanos, 1999; Mills, Kincaid, Alt, Heilman, & Hill, 2000; Sica et al., 2008) . M2 MΦs display specific receptors known as haemoglobin scavenger receptor (CD163), macrophage scavenger receptor I (CD204), and mannose receptor (CD206; Yokozaki, Koma, Shigeoka, & Nishio, 2018) . We previously demonstrated that the infiltration of a high number of CD204 + TAMs was associated with tumour aggressiveness in oesophageal squamous cell carcinoma cases (Shigeoka et al., 2013; Shigeoka et al., 2015) . The results of many studies suggested that CD163 is a useful marker for
TAMs that contribute to the progression and development of OSCC (Fujii et al., 2012; He et al., 2014; Troiano et al., 2019; Usami et al., 2013; Yamagata et al., 2017) . However, the role of MΦs in early oral carcinogenesis has not been elucidated.
The concept of tumour immunosuppression has been reported by many researchers (Dunn, Bruce, Ikeda, Old, & Schreiber, 2002; Schreiber, Old, & Smyth, 2011) and several studies on human cancers including OSCC have indicated that TAMs suppress anti-tumour immunity (Kubota et al., 2017; Takeya & Komohara, 2016; Wen et al., 2018 
| MATERIALS AND METHODS

| Tissue samples
| Morphological evaluation
Three pathologists (M. S., Y. K. and H. Y.), blinded to the patients' clinical data of the patients, performed the grading of epithelial dysplasia based on the modified squamous intraepithelial neoplasia system (Yagyuu et al., 2015; Yagyuu et al., 2017) . Briefly, the degree of dysplasia was divided into high (moderate/severe dysplasia or carcinoma in situ) and low (no/mild dysplasia) grades. In this study, not only the basaloid-type but also the differentiated-type carcinoma in situ were classified as high grade.
| Immunohistochemical evaluation
We used a modified version of the immunoglobulin enzyme bridge technique with the Linked Streptavidin-Biotin Kit (DakoCytomation, Glostrup, Denmark) as described elsewhere (Shigeoka et al., 2013 assessed with a modified version of a previous method (Yagyuu et al., 2015) . Briefly, the Ki-67 expression was evaluated as a second basal layer or an unclear or basal layer and/or more superficial layer. The 
| Cell cultures
HOKs were purchased from ScienCell Research Laboratories were stimulated with 100 nM 12-O-tetradecanoylphorbol 13-acetate (TPA; Cell Signaling, Danvers, MA, USA) for 48 hr, and the medium was then changed to complete oral keratinocyte medium (ScienCell).
Before the medium was changed, to remove TPA sufficiently from the well, we aspirated well and washed using PBS, three times in the present study. After 2 days, the supernatant was harvested, centrifuged, and stored in aliquots at −80 C.
| Quantitative reverse transcription-polymerase chain reaction
Total 
| Western blot analysis
Cells were lysed in a buffer containing 50 mM Tris-HCl (pH 7.4), 125 mM NaCl, 0.1% Triton X-100, and 5 mM ethylenediaminetetraacetic acid with a 1% protease inhibitor cocktail 
| Enzyme-linked immunosorbent assay
Human IL-10 concentrations were measured by the Quantkine ELISA Human IL-10 Immunoassay (R&D, MN, USA) according to the manufacturer's instructions. The optical density of each well was read at 450 and 540 nm. The concentration of IL-10 was calculated using a standard curve and the measured absorbance.
. Table 2 ).
| Statistical analysis
| DISCUSSION
Several studies have shown that the infiltration of CD163 + MΦs positively correlates with epithelial dysplasia and the malignancy of oral precancerous lesion (Mori, Haraguchi, Hiori, Shimada, & Ohmori, 2015; Stasikowska-Kanicka et al., 2018b) . Additionally, previous studies have shown that the number of Tregs and the levels of IL-10 expression increase in oral precancerous lesions (Goncalves et al., 2017; Sun et al., 2016) . However, to the best of our knowledge, this is the first study to demonstrate the association of CD163 + MΦs infiltration with IL-10 expression in TL.
The results of our analyses demonstrated that the number of infil- (Fujii et al., 2012; Wang et al., 2014) . It was reported that CD163 + MΦs are distributed not only in the cancer stroma but also within the cancer nest in OSCC (Usami et al., 2013) . On the other hand, it has been shown that the majority of infiltrating CD163 + MΦs were distributed in the subepithelial stroma in OL (Mori et al., 2015) . In accordance with these reports, we observed herein that CD163 + MΦs were distributed in the subepithelial stroma, especially beneath the basement membrane.
Many reports have shown the importance of a direct interaction between MΦs and cancer cells (Komohara et al., 2013; Komohara, Ohnishi, Kuratsu, & Takeya, 2008; Usami et al., 2013) . We speculate phenotype (Mori et al., 2015) . Essa et al. (2016) (Guan et al., 2007) . Sun et al. (2016) reported that IL-10 expression levels gradually increased during the early stages of OL and in OSCC (Sun et al., 2016) . Kubota et al. (2017) revealed that TAMs promote T cell regulation via IL-10 and PD-L1 production in OSCC (Kubota et al., 2017) . Our present findings also showed that the expression level of IL-10 was significantly positively correlated with the infiltration of Tregs in TL. It is speculated that IL-10 induced by CD163 + MΦs may contribute to the infiltration of Tregs during the development of oral carcinogenesis.
There are three limitations in this study. First, the sample size (n = 24) was small. At our hospital, the first choice of treatment for leukoplakia occurring in parts other than the tongue (including the gingiva or the palate) is vaporisation with a CO 2 laser instead of surgical resection; it is thus difficult to perform several histopathological examinations. Second, we have not verified the effect of IL-10 on Tregs using in vitro assays. Mori et al. (2015) proposed that the infiltration of MΦs and T cells into epithelial lesions may be involved in early morphological changes in the development of dysplasia (Mori et al., 2015) . To overcome these limitations, it may be necessary to undertake an accurate study with a large sample size or an in vitro study with not only HOKs and THP-1 cells but also with T cells. Third, we did not analyse the nature of the CD163 + MΦ-like cells CM that induced the IL-10 expression in HOK. We speculated that the humoral factor(s) from CD163 + MΦs is one of the important inducers of IL-10 in TL. It is reported that IL-10 is produced by monocytes or T cells (Del Prete et al., 1993; Konjevic, Vuletic, Mirjacic Martinovic, Larsen, & Jurisic, 2019) . There are many reports on the inducer of IL-10. The induction of IL-10 from Tregs is reported to be dependent on TGF-β, but IL-10, IL-2, and IL-4 also help to promote its optimal production (Josefowicz, Lu, & Rudensky, 2012; Ouyang & O'Garra, 2019) .
In mouse models of malaria, IL-27 is an important regulator of IL-10
producing Type 1 regulatory T (Tr1) cells (Kumar, Ng, & Engwerda, 2019) . Kumar et al. (2019) also showed that Type I interferons (IFNs) are also critical regulators of IL-10 production by Tr1 cells (Kumar et al., 2019) . It is showed that the increasing plasma IL-10 levels observed during exercise are mediated by IL-6 from contracting muscles (Steensberg, Fischer, Keller, Moller, & Pedersen, 2003) . Comprehensive analysis of CD163 + THP-1 CM using cytokine array or cDNA microarray should be further conducted.
Overall, our results indicated that CD163 + MΦs might play important roles in the development of TL via immunosuppression. Immunological approaches targeting IL-10 could be effective for the establishment of novel therapies of OL. 
